• Log-in
    Register
  • Therapeutic Areas
    • Pain/Osteoarthritis
    • Cardiovascular
    • Men's Health
    • Respiratory/Allergy
    • Opthalmology
    • Gastroenterology
    • Dermatology
    • Psychiatry
    • Neurology
    • Urology
  • Viatris Medicines
    • Log-in/Register
  1. Home
  2. Therapeutic Areas
  3. Zoloft®

Zoloft®

<
    >

    Zoloft®

    Mode of Action

    Mechanism of Action

    Significant improvements of depressive symptoms with ZOLOFT® vs placebo at Week 8, as measured by HAM-D17

    EFFICACY

    SAFETY & TOLERABILITY

    SAFETY & TOLERABILITY

     DOSING & ADMINISTRATION

    Posology & Method of Administration

    Treatment Guidelines

    Treatment Guidelines

    Clinical Information

    Clinical Information

    Patient Profiles

    Patient Profiles

    Celebrex Safety

    Prof Nemeroff Video - MDD in chronic conditions

    Celebrex Safety

    Brain Circuits - Personalized Approach to a Patient

    Follow Us

    • Contact Us
    • Adverse Events Reporting
    • Cookie Notice
    • Privacy Policy
    • Terms and Conditions

    Copyright © 2023 Viatris Middle East FZ-LLC FZ LLC. All rights reserved.

    The product information provided in this site is intended only for Healthcare Professionals of Gulf Countries*. The products discussed herein may have different product labeling in different countries.

    The information provided on this website is intended only for healthcare professionals of Gulf Countries*

    *UAE, Bahrain, Qatar, Oman, Iraq and Kuwait.

    NON-2023-10886

    Leaving the Viatris site

    You are leaving the Viatris site to a Viatris affiliated site or a third-party site, who is responsible for its content, including compliance with applicable guidelines in certain areas. Links to Viatris affiliated sites and third-party sites are provided as a resource to our visitors and may or may not be governed by the same regulatory requirements applicable to this site and unaffiliated third-party sites are subject to their own terms, notices and personal data protection practices. In addition, if a third-party site is subject to the laws of other countries, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided may not be appropriate for use in the Gulf markets (United Arab Emirates, Kuwait, Qatar, Oman, Bahrain and Iraq).
    Continue
    Cancel